MedTrace Logo

Evaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following Abdominoplasty

NCT05412992 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 179

Last updated 2025-12-24

No results posted yet for this study

Summary

The primary objective of this study is to evaluate the analgesic efficacy of DMTS, compared with placebo, in subjects following abdominoplasty.

Conditions

  • Pain, Postoperative

Interventions

DRUG

DMTS Patch

DMTS applied before surgery and worn for 96 hours

DRUG

Placebo Patch

Matching patches that have no active drug applied before surgery and worn for 96 hours

Sponsors & Collaborators

  • Teikoku Pharma USA, Inc.

    lead INDUSTRY

Principal Investigators

  • James Song, MS, MA · Teikoku Pharma USA, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-07
Primary Completion
2023-04-19
Completion
2023-04-19
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05412992 on ClinicalTrials.gov